Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline

BACKGROUND: Strokes are becoming less severe due to increased numbers of intensive care units and improved treatments. As patients survive longer, post-stroke cognitive impairment (PSCI) has become a major health public issue. Diabetes has been identified as an independent predictive factor for PSCI...

Descripción completa

Detalles Bibliográficos
Autores principales: Cogo, Adrien, Mangin, Gabrielle, Maïer, Benjamin, Callebert, Jacques, Mazighi, Mikael, Chabriat, Hughes, Launay, Jean-Marie, Huberfeld, Gilles, Kubis, Nathalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885563/
https://www.ncbi.nlm.nih.gov/pubmed/33588894
http://dx.doi.org/10.1186/s13024-020-00421-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885563/
https://www.ncbi.nlm.nih.gov/pubmed/33588894
http://dx.doi.org/10.1186/s13024-020-00421-4

Ejemplares similares